Cargando…

Painful Diabetic Neuropathy: Advantage of novel drugs over old drugs?

Detalles Bibliográficos
Autor principal: Ziegler, Dan
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811478/
https://www.ncbi.nlm.nih.gov/pubmed/19875591
http://dx.doi.org/10.2337/dc09-S350
_version_ 1782176772378329088
author Ziegler, Dan
author_facet Ziegler, Dan
author_sort Ziegler, Dan
collection PubMed
description
format Text
id pubmed-2811478
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-28114782010-11-01 Painful Diabetic Neuropathy: Advantage of novel drugs over old drugs? Ziegler, Dan Diabetes Care Diagnosis and Treatment of Microvascular Disease American Diabetes Association 2009-11 /pmc/articles/PMC2811478/ /pubmed/19875591 http://dx.doi.org/10.2337/dc09-S350 Text en © 2009 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Diagnosis and Treatment of Microvascular Disease
Ziegler, Dan
Painful Diabetic Neuropathy: Advantage of novel drugs over old drugs?
title Painful Diabetic Neuropathy: Advantage of novel drugs over old drugs?
title_full Painful Diabetic Neuropathy: Advantage of novel drugs over old drugs?
title_fullStr Painful Diabetic Neuropathy: Advantage of novel drugs over old drugs?
title_full_unstemmed Painful Diabetic Neuropathy: Advantage of novel drugs over old drugs?
title_short Painful Diabetic Neuropathy: Advantage of novel drugs over old drugs?
title_sort painful diabetic neuropathy: advantage of novel drugs over old drugs?
topic Diagnosis and Treatment of Microvascular Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811478/
https://www.ncbi.nlm.nih.gov/pubmed/19875591
http://dx.doi.org/10.2337/dc09-S350
work_keys_str_mv AT zieglerdan painfuldiabeticneuropathyadvantageofnoveldrugsoverolddrugs